Company profile · Other
Diamond Biofund
鑽石生技投資股份有限公司 · 6901
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Diamond Biofund is a venture capital company that specializes in investments in the biotechnology and pharmaceutical industries.[1]
The company focuses on investment targets in the early and middle stages globally, including new drug R&D, high-end medical devices, medical services, medical channels, and agricultural biotech.[1]
Major investment targets include Cho Pharma, Inc., Sinew Pharma Inc., Tetanti AgriBiotech Inc., and StemCyte International Ltd.[1]
Its registered business activities include biotechnology services and research and development services.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$-690m | +447.8% | -302.0% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$18m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | DIAMOND BIOFUND INC. |
|---|---|
| Chinese name | 鑽石生技投資股份有限公司 |
| Stock code | 6901 (TWSE) |
| Industry | Other |
| Founded | 09 Jan 2013 |
| Listed | 19 Sep 2023 |
| Paid-in capital | NT$8.5bn |
| Chairman | 楊泮池 |
| President | 路孔明 |
| Headquarters | 35F, No. 66, Sec. 1, Zhongxiao W. Rd., Zhongzheng Dist. Taipei City 100507, Taiwan (R.O.C.) |
| Website | http://www.diamondbiofund.com |
| Official business description | 創業投資業 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list